Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City.
J Oncol Pharm Pract. 2021 Mar;27(2):389-394. doi: 10.1177/1078155220987625. Epub 2021 Jan 17.
J Oncol Pharm Pract. 2021.
PMID: 33459159
Free PMC article.
Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia.
Reiss SN, Buie LW, Adel N, Goldman DA, Devlin SM, Douer D.
Reiss SN, et al.
Ann Hematol. 2016 Dec;95(12):2009-2015. doi: 10.1007/s00277-016-2795-7. Epub 2016 Aug 20.
Ann Hematol. 2016.
PMID: 27542957
Free PMC article.
Item in Clipboard
Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas.
Reiss SN, Yerram P, Modelevsky L, Grommes C.
Reiss SN, et al.
J Immunother Cancer. 2017 Dec 19;5(1):99. doi: 10.1186/s40425-017-0302-x.
J Immunother Cancer. 2017.
PMID: 29254497
Free PMC article.
Item in Clipboard
Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma.
Modelevsky L, Tizon R, Reiss SN, Smith M, Garonce R, Kaley T.
Modelevsky L, et al. Among authors: reiss sn.
CNS Oncol. 2018 Jul 1;7(3):CNS19. doi: 10.2217/cns-2018-0001. Epub 2018 Sep 17.
CNS Oncol. 2018.
PMID: 30221993
Free PMC article.
Item in Clipboard
Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
Yerram P, Reiss SN, Modelevsky L, Gavrilovic IT, Kaley T.
Yerram P, et al. Among authors: reiss sn.
J Neurooncol. 2019 Oct;145(1):57-63. doi: 10.1007/s11060-019-03266-0. Epub 2019 Aug 20.
J Neurooncol. 2019.
PMID: 31432377
Free PMC article.
Clinical Trial.
Item in Clipboard
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Reiss SN, Yerram P, Modelevsky L, Grommes C.
Reiss SN, et al.
Leuk Lymphoma. 2022 Mar;63(3):627-632. doi: 10.1080/10428194.2021.1998481. Epub 2021 Nov 10.
Leuk Lymphoma. 2022.
PMID: 34758711
Free PMC article.
Item in Clipboard
Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort.
Yerram P, Reiss SN, Modelevsky L, Schaff L, Reiner AS, Panageas KS, Grommes C.
Yerram P, et al. Among authors: reiss sn.
Ann Lymphoma. 2023 Feb 28;7:1. doi: 10.21037/aol-22-19.
Ann Lymphoma. 2023.
PMID: 37067886
Free PMC article.
Item in Clipboard
Cite
Cite